Medisch Spectrum Twente-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2003

  1. A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

    Annals of Oncology, Vol. 14, Núm. 1, pp. 29-35